These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 11817007

  • 21. Effect of lodoxamide on tear leukotriene levels in giant papillary conjunctivitis associated with ocular prosthesis.
    Akman A, Irkeç M, Orhan M, Erdener U.
    Ocul Immunol Inflamm; 1998 Sep; 6(3):179-84. PubMed ID: 9785608
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.
    Rodriguez-Garcia A, Macias-Rodriguez Y, Gonzalez-Gonzalez JM.
    Int Ophthalmol; 2018 Jun; 38(3):1243-1249. PubMed ID: 28602013
    [Abstract] [Full Text] [Related]

  • 23. Effects of ketotifen 0.025% and lodoxamide 0.1% on eosinophil infiltration into the guinea pig conjunctiva in a model of allergic conjunctivitis.
    Schoch C.
    J Ocul Pharmacol Ther; 2003 Apr; 19(2):153-9. PubMed ID: 12804060
    [Abstract] [Full Text] [Related]

  • 24. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
    Greiner JV, Udell IJ.
    Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305
    [Abstract] [Full Text] [Related]

  • 25. Contrast sensitivity and tear layer aberrometry in dry eye patients.
    Ridder WH, LaMotte J, Hall JQ, Sinn R, Nguyen AL, Abufarie L.
    Optom Vis Sci; 2009 Sep; 86(9):E1059-68. PubMed ID: 19648840
    [Abstract] [Full Text] [Related]

  • 26. Lodoxamide treatment of allergic conjunctivitis.
    Cerqueti PM, Ricca V, Tosca MA, Buscaglia S, Ciprandi G.
    Int Arch Allergy Immunol; 1994 Oct; 105(2):185-9. PubMed ID: 7920019
    [Abstract] [Full Text] [Related]

  • 27. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions.
    Enzenauer RW, Kao A, Williams T, Lambert RW.
    Eye Contact Lens; 2003 Oct; 29(4):238-40. PubMed ID: 14555900
    [Abstract] [Full Text] [Related]

  • 28. Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye.
    Roberts CW, Carniglia PE, Brazzo BG.
    Cornea; 2007 Aug; 26(7):805-9. PubMed ID: 17667613
    [Abstract] [Full Text] [Related]

  • 29. Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients.
    Di Pascuale MA, Goto E, Tseng SC.
    Ophthalmology; 2004 Apr; 111(4):783-91. PubMed ID: 15051213
    [Abstract] [Full Text] [Related]

  • 30. Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study.
    Troiano P, Monaco G.
    Cornea; 2008 Dec; 27(10):1126-30. PubMed ID: 19034126
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the efficacy of two lipid emulsion eyedrops in increasing tear film lipid layer thickness.
    Scaffidi RC, Korb DR.
    Eye Contact Lens; 2007 Jan; 33(1):38-44. PubMed ID: 17224677
    [Abstract] [Full Text] [Related]

  • 32. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
    Yoon KC, Heo H, Im SK, You IC, Kim YH, Park YG.
    Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
    [Abstract] [Full Text] [Related]

  • 33. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
    Kim EC, Choi JS, Joo CK.
    Am J Ophthalmol; 2009 Feb; 147(2):206-213.e3. PubMed ID: 18848318
    [Abstract] [Full Text] [Related]

  • 34. Clinical and economic implications of topical cyclosporin A for the treatment of dry eye.
    Cross WD, Lay LF, Walt JG, Kozma CM.
    Manag Care Interface; 2002 Sep; 15(9):44-9. PubMed ID: 12244650
    [Abstract] [Full Text] [Related]

  • 35. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye.
    Matsuo T.
    Jpn J Ophthalmol; 2004 Sep; 48(4):321-7. PubMed ID: 15295655
    [Abstract] [Full Text] [Related]

  • 36. [In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
    Blondin C, Cholley B, Haeffner-Cavaillon N, Goldschmidt P.
    J Fr Ophtalmol; 2003 Apr; 26(4):328-36. PubMed ID: 12843888
    [Abstract] [Full Text] [Related]

  • 37. Tear histamine and histaminase during the early (EPR) and late (LPR) phases of the allergic reaction and the effects of lodoxamide.
    Leonardi AA, Smith LM, Fregona IA, Salmaso M, Secchi AG.
    Eur J Ophthalmol; 1996 Apr; 6(2):106-12. PubMed ID: 8823580
    [Abstract] [Full Text] [Related]

  • 38. Randomised double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study.
    Fahy GT, Easty DL, Collum LM, Benedict-Smith A, Hillery M, Parsons DG.
    Eur J Ophthalmol; 1992 Apr; 2(3):144-9. PubMed ID: 1450659
    [Abstract] [Full Text] [Related]

  • 39. United States cost-effectiveness study of two dry eye ophthalmic lubricants.
    Wlodarczyk J, Fairchild C.
    Ophthalmic Epidemiol; 2009 Apr; 16(1):22-30. PubMed ID: 19191178
    [Abstract] [Full Text] [Related]

  • 40. Menopause and dry eye. A possible relationship.
    Versura P, Campos EC.
    Gynecol Endocrinol; 2005 May; 20(5):289-98. PubMed ID: 16019376
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.